Stay in the Know

Early detection, diagnosis and treatment of chronic kidney disease (CKD) are critical to improving chronic disease outcomes in the United States. Recent research has identified improvements in CKD screening rates among Medicare enrollees, but less is known about whether these gains are translating into earlier-stage diagnosis.

Manatt Entertainment Partner John Meller authored an article for Music Business Worldwide outlining a creator-first framework for ethical AI music licensing, grounded in three principles: consent, fair compensation and transparency.

The piece argues that recording artist and songwriter approvals are non-negotiable in any ethical and commercially viable AI music offering and outlines Meller's principles for how royalties should be structured for AI training uses. He also addresses the importance of protecting artists' vocal rights, establishing transparency systems to track AI usage and preparing for contingencies when AI-generated content escapes controlled platforms.

"Generative AI use in music creation must put songwriters and recording artists first. Their life's work is the backbone of our industry and, if licensed, the golden ticket to potential success for AI music offerings," wrote Meller.

Read the full Music Business Worldwide article here.

On August 14, 2026, the Securities and Exchange Commission (“SEC”) approved amendments to the NYSE American (the “Exchange”) continued listing standards that establish a new $0.25 minimum trading price for listed securities. Under the new NYSE American Company Guide, if a security’s closing price per share falls below $0.25 on any trading day, NYSE American will immediately suspend trading and commence delisting proceedings. The rule will become effective July 1, 2027, nine months later than the originally proposed October 1, 2026 implementation date.